儿科息护理在中国大陆的发展状况和五年演变
Siyu Cai1, Xiaoxia Peng1, Qiaohong Guo2
1Center for Clinical Epidemiology and Evidence-Based Medicine (S.C., X.P.), National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, China.
Journal of pain and symptom management
|November 7, 2025
概括
中国的儿科息护理 (PPC) 显示了改善的团队结构和扩展的服务. 然而,由于资源短缺和分配不均,挑战仍然存在,影响了护理的可获得性.
科学领域:
- 儿科医疗保健研究的研究.
- 抚慰性护理的发展
- 医疗保健系统分析分析
背景情况:
- 儿科息护理 (PPC) 在整个儿童疾病轨迹中至关重要.
- 整合PPC对于强大的儿科医疗保健系统至关重要.
研究的目的:
- 评估中国大陆PPC开发的现状.
- 分析过去五年 (2019-2025) PPC特征的变化.
主要方法:
- 对中国大陆所有PPC团队进行横截面研究.
- 通过关于团队特征,服务和需求的问卷收集的数据.
- 对2025年数据与2019年以前文献数据进行比较分析.
主要成果:
- PPC团队从45人减少到36人,但总成员从300人增加到513人 (2019-2025年).
- 在PPC团队中观察到显著的结构性改善.
- 息护理服务内容随着改善的团队结构而显著扩大.
结论:
- 中国的PPC系统在过去五年里增强了团队结构和动态.
- 持续的挑战包括严重的资源短缺和低效的利用.
- 电信服务的地理分布不均仍然是一个重大问题.
相关概念视频
Continuing Care
1.8K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Primary Healthcare Services
1.9K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.9K
Methods Of Healthcare Delivery System
3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
182
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634

